Loading viewer...
investor_presentation
Format: PDF investor_presentation
MIRA Pharmaceuticals, Inc. IPO prospectus for July 2023 offering on NASDAQ Capital Market at $7.00 per share. The company is developing early-stage preclinical pharmaceutical product candidates with proceeds directed toward clinical development and general corporate purposes.
20 Pages
investor_presentation
42 Pages
Elia Group
Al Ansari Financial Services Q3 2023 Investor Presentation
investor_presentationinvestor_presentation
21 Pages
Al Ansari Financial Services PJSC